MiRXES (觅瑞早筛)
Singapore, Singapore
MiRXES is a Singapore-headquartered biotechnology company whose mission is to improve and save lives through disease early detection tests. We are Asia-centered, starting with Southeast Asia, and have global ambitions. We have research, development, manufacturing, and clinical diagnostic operations in Singapore, USA, Japan, and China. We have sales and distribution networks worldwide. MiRXES flagship product is GASTROClear, the world’s first molecular blood test for early detection of gastric cancer, able to detect around 90% of patients with Stage I and II cancers.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2014
- Website
- www.mirxes.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of MiRXES (觅瑞早筛)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now